NCPA is suing the government to end DIR fees. Doing so has been our top priority since 2014. We tried every year of the outgoing administration to persuade the Department of Health and Human Services to adopt new rules to remedy the problem. That effort nearly succeeded in 2019, only to have it die because of opposition from the White House. Having exhausted every effort to work through the legislative and regulatory processes, community pharmacies can wait no longer.
NCPA Digest Sponsored By Cardinal Health
NCPA is pleased to present you with the NCPA Digest, sponsored by Cardinal Health. The Digest is a summary of selected financial and demographic information that illustrates the independent community pharmacy market and the valuable services these pharmacies deliver to their patients. It is the most comprehensive report on independent community pharmacy available. Historically, the NCPA Digest has utilized NCPDP data as the base for its pharmacy count analysis. Consistent normalization to the NCPDP data has been conducted annually to produce NCPA’s final pharmacy counts as published in the Digest. Starting with this release of the 2021 Digest, NCPA moved to IQVIA, the leading source for pharmaceutical data in the industry, as our benchmark for store counts.
Your Neighbor: Benefits of an Independent Pharmacist
Your local independent pharmacists are your most accessible healthcare professionals and take the time to truly connect and consult with each patient they serve.
NCPA has been monitoring the information and guidance provided by the CDC and other government agencies, and is advocating on behalf of independent community pharmacies on the front lines.
NCPA CBD Source
NCPA has partnered with PRS to create a digital resource for CBD products, as well as an educational platform for pharmacists designated to give them the information they need to confidently advise their patients on all things CBD.